{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:11:13Z","timestamp":1794006673978,"version":"4.8.0"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institute of Health funds","doi-asserted-by":"publisher","award":["R01AI173214 to A.H., R01AI185026 to G.C."],"award-info":[{"award-number":["R01AI173214 to A.H., R01AI185026 to G.C."]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun. Inflamm."],"DOI":"10.1007\/s44466-025-00014-0","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T23:02:38Z","timestamp":1756940558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["NF-\u03baB: master regulator of cellular responses in health and disease"],"prefix":"10.1007","volume":"1","author":[{"given":"Alexander","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baltimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0092-8674(86)90807-X","volume":"47","author":"R Sen","year":"1986","unstructured":"Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47:921\u20138.","journal-title":"Cell"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/326711a0","volume":"326","author":"G Nabel","year":"1987","unstructured":"Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 1987;326:711\u20133.","journal-title":"Nature"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","volume":"87","author":"PA Baeuerle","year":"1996","unstructured":"Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87:13\u201320.","journal-title":"Cell"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621\u201363.","journal-title":"Annu Rev Immunol"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1071914","volume":"298","author":"A Hoffmann","year":"2002","unstructured":"Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science. 2002;298:1241\u20135.","journal-title":"Science"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1101\/gad.1680708","volume":"22","author":"SL Werner","year":"2008","unstructured":"Werner SL, Kearns JD, Zadorozhnaya V, et al. Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev. 2008;22:2093\u2013101.","journal-title":"Genes Dev"},{"key":"14_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaa5208","volume":"8","author":"Z Cheng","year":"2015","unstructured":"Cheng Z, Taylor B, Ourthiague DR, Hoffmann A. Distinct single-cell signaling characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation. Sci Signal. 2015;8:ra69.","journal-title":"Sci Signal"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.immuni.2021.04.011","volume":"54","author":"A Adelaja","year":"2021","unstructured":"Adelaja A, Taylor B, Sheu KM, et al. Six distinct NF\u03baB signaling codons convey discrete information to distinguish stimuli and enable appropriate macrophage responses. Immunity. 2021;54:916-930.e7.","journal-title":"Immunity"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","volume":"17","author":"E Dejardin","year":"2002","unstructured":"Dejardin E, Droin NM, Delhase M, et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 2002;17:525\u201335.","journal-title":"Immunity"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ni842","volume":"3","author":"E Claudio","year":"2002","unstructured":"Claudio E, Brown K, Park S, et al. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol. 2002;3:958\u201365.","journal-title":"Nat Immunol"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/cr.2010.161","volume":"21","author":"VF-S Shih","year":"2011","unstructured":"Shih VF-S, Tsui R, Caldwell A, Hoffmann A. A single NF\u03baB system for both canonical and non-canonical signaling. Cell Res. 2011;21:86\u2013102.","journal-title":"Cell Res"},{"key":"14_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abo2838","volume":"16","author":"S Mitchell","year":"2023","unstructured":"Mitchell S, Tsui R, Tan ZC, et al. The NF-\u03baB multidimer system model: a knowledge base to explore diverse biological contexts. Sci Signal. 2023;16:eabo2838.","journal-title":"Sci Signal"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","volume":"16","author":"S Ghosh","year":"1998","unstructured":"Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225\u201360.","journal-title":"Annu Rev Immunol"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.0105-2896.2006.00375.x","volume":"210","author":"A Hoffmann","year":"2006","unstructured":"Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev. 2006;210:171\u201386.","journal-title":"Immunol Rev"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1038\/sj.onc.1209933","volume":"25","author":"A Hoffmann","year":"2006","unstructured":"Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene. 2006;25:6706\u201316.","journal-title":"Oncogene"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132:344\u201362.","journal-title":"Cell"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni0302-221","volume":"3","author":"M Karin","year":"2002","unstructured":"Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3:221\u20137.","journal-title":"Nat Immunol"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356\u201361.","journal-title":"Nature"},{"key":"14_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000109","volume":"2","author":"LM Staudt","year":"2010","unstructured":"Staudt LM. Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol. 2010;2:a000109.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P. Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement. 2016;12:719\u201332.","journal-title":"Alzheimers Dement"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","volume":"1799","author":"SC Gupta","year":"2010","unstructured":"Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta. 2010;1799:775\u201387.","journal-title":"Biochim Biophys Acta"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nri3446","volume":"13","author":"LAJ O\u2019Neill","year":"2013","unstructured":"O\u2019Neill LAJ, Golenbock D, Bowie AG. The history of toll-like receptors - redefining innate immunity. Nat Rev Immunol. 2013;13:453\u201360.","journal-title":"Nat Rev Immunol"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11:373\u201384.","journal-title":"Nat Immunol"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181\u201390.","journal-title":"Cell"},{"key":"14_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003004","volume":"2","author":"M Thome","year":"2010","unstructured":"Thome M, Charton JE, Pelzer C, Hailfinger S. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol. 2010;2:a003004.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/embr.201337983","volume":"15","author":"M Hinz","year":"2014","unstructured":"Hinz M, Scheidereit C. The I\u03baB kinase complex in NF-\u03baB regulation and beyond. EMBO Rep. 2014;15:46\u201361.","journal-title":"EMBO Rep"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"15942","DOI":"10.1074\/jbc.M500814200","volume":"280","author":"R Fagerlund","year":"2005","unstructured":"Fagerlund R, Kinnunen L, K\u00f6hler M, et al. NF-kappaB is transported into the nucleus by importin alpha3 and importin alpha4. J Biol Chem. 2005;280:15942\u201351.","journal-title":"J Biol Chem"},{"key":"14_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001647","volume":"11","author":"SP Mukherjee","year":"2013","unstructured":"Mukherjee SP, Behar M, Birnbaum HA, et al. Analysis of the RelA:CBP\/p300 interaction reveals its involvement in NF-\u03baB-driven transcription. PLoS Biol. 2013;11:e1001647.","journal-title":"PLoS Biol"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1016\/j.celrep.2020.01.108","volume":"30","author":"KA Ngo","year":"2020","unstructured":"Ngo KA, Kishimoto K, Davis-Turak J, et al. Dissecting the Regulatory Strategies of NF-\u03baB RelA Target Genes in the Inflammatory Response Reveals Differential Transactivation Logics. Cell Rep. 2020;30:2758-2775.e6.","journal-title":"Cell Rep"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"19328","DOI":"10.1073\/pnas.0908797106","volume":"106","author":"S Bergqvist","year":"2009","unstructured":"Bergqvist S, Alverdi V, Menge B, et al. Kinetic enhancement of NF-kappaBxDNA dissociation by IkappaBalpha. Proc Natl Acad Sci U S A. 2009;106:19328\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1073\/pnas.1610192114","volume":"114","author":"HE Dembinski","year":"2017","unstructured":"Dembinski HE, Wismer K, Vargas JD, et al. Functional importance of stripping in NF\u03baB signaling revealed by a stripping-impaired I\u03baB\u03b1 mutant. Proc Natl Acad Sci U S A. 2017;114:1916\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR32","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2015.0262","volume":"12","author":"R Fagerlund","year":"2015","unstructured":"Fagerlund R, Behar M, Fortmann KT, et al. Anatomy of a negative feedback loop: the case of I\u03bab\u03b1. J R Soc Interface. 2015;12:0262.","journal-title":"J R Soc Interface"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1128\/MCB.20.6.2269-2284.2000","volume":"20","author":"WF Tam","year":"2000","unstructured":"Tam WF, Lee LH, Davis L, Sen R. Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export. Mol Cell Biol. 2000;20:2269\u201384.","journal-title":"Mol Cell Biol"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cels.2019.12.004","volume":"10","author":"S Sen","year":"2020","unstructured":"Sen S, Cheng Z, Sheu KM, et al. Gene Regulatory Strategies that Decode the Duration of NF\u03baB Dynamics Contribute to LPS- versus TNF-Specific Gene Expression. Cell Syst. 2020;10:169-182.e5.","journal-title":"Cell Syst"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.immuni.2011.01.014","volume":"34","author":"SM Wuerzberger-Davis","year":"2011","unstructured":"Wuerzberger-Davis SM, Chen Y, Yan DT, et al. Nuclear export of the NF-\u03baB inhibitor I\u03baB\u03b1 is required for proper B cell and secondary lymphoid tissue formation. Immunity. 2011;34:188\u2013200.","journal-title":"Immunity"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4049\/jimmunol.2000039","volume":"205","author":"DN Lisiero","year":"2020","unstructured":"Lisiero DN, Cheng Z, Teje MM, et al. I\u03baB\u03b1 nuclear export enables 4\u20131BB-induced c-Rel activation and IL-2 production to promote CD8 T+ cell immunity. J Immunol. 2020;205:1540\u201353.","journal-title":"J Immunol"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1083\/jcb.200510155","volume":"173","author":"JD Kearns","year":"2006","unstructured":"Kearns JD, Basak S, Werner SL, et al. IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol. 2006;173:659\u201364.","journal-title":"J Cell Biol"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.4049\/jimmunol.1302351","volume":"192","author":"BN Alves","year":"2014","unstructured":"Alves BN, Tsui R, Alma J, et al. I\u03baB\u03b5 is a key regulator of B cell expansion by providing negative feedback on c-Rel and RelA in a stimulus-specific manner. J Immunol. 2014;192:3121\u201332.","journal-title":"J Immunol"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2006.12.033","volume":"128","author":"S Basak","year":"2007","unstructured":"Basak S, Kim H, Kearns JD, et al. A fourth IkappaB protein within the NF-kappaB signaling module. Cell. 2007;128:369\u201381.","journal-title":"Cell"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1073\/pnas.0812367106","volume":"106","author":"VF-S Shih","year":"2009","unstructured":"Shih VF-S, Kearns JD, Basak S, et al. Kinetic control of negative feedback regulators of NF-kappaB\/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proc Natl Acad Sci U S A. 2009;106:9619\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wsbm.1331","volume":"8","author":"S Mitchell","year":"2016","unstructured":"Mitchell S, Vargas J, Hoffmann A. Signaling via the NF\u03baB system. Wiley Interdiscip Rev Syst Biol Med. 2016;8:227\u201341.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1600-065X.2011.01092.x","volume":"246","author":"S Basak","year":"2012","unstructured":"Basak S, Behar M, Hoffmann A. Lessons from mathematically modeling the NF-\u03baB pathway. Immunol Rev. 2012;246:221\u201338.","journal-title":"Immunol Rev"},{"key":"14_CR43","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.immuni.2021.08.018","volume":"54","author":"S Luecke","year":"2021","unstructured":"Luecke S, Sheu KM, Hoffmann A. Stimulus-specific responses in innate immunity: multilayered regulatory circuits. Immunity. 2021;54:1915\u201332.","journal-title":"Immunity"},{"key":"14_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60901-3","volume":"16","author":"X Guo","year":"2025","unstructured":"Guo X, Adelaja A, Singh A, et al. Modeling heterogeneous signaling dynamics of macrophages reveals principles of information transmission in stimulus responses. Nat Commun. 2025;16:5986.","journal-title":"Nat Commun"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/emboj.2008.73","volume":"27","author":"E Mathes","year":"2008","unstructured":"Mathes E, O\u2019Dea EL, Hoffmann A, Ghosh G. NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO J. 2008;27:1357\u201367.","journal-title":"EMBO J"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/msb4100148","volume":"3","author":"EL O\u2019Dea","year":"2007","unstructured":"O\u2019Dea EL, Barken D, Peralt RQ, et al. A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol. 2007;3:111.","journal-title":"Mol Syst Biol"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/wsbm.30","volume":"1","author":"E O\u2019Dea","year":"2009","unstructured":"O\u2019Dea E, Hoffmann A. NF-\u03baB signaling. Wiley Interdiscip Rev Syst Biol Med. 2009;1:107\u201315.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"14_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045078","volume":"7","author":"AB Tam","year":"2012","unstructured":"Tam AB, Mercado EL, Hoffmann A, Niwa M. ER stress activates NF-\u03baB by integrating functions of basal IKK activity, IRE1 and PERK. PLoS One. 2012;7:e45078.","journal-title":"PLoS One"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.molcel.2008.03.017","volume":"30","author":"EL O\u2019Dea","year":"2008","unstructured":"O\u2019Dea EL, Kearns JD, Hoffmann A. UV as an amplifier rather than inducer of NF-kappaB activity. Mol Cell. 2008;30:632\u201341.","journal-title":"Mol Cell"},{"key":"14_CR50","volume":"2","author":"E O\u2019Dea","year":"2010","unstructured":"O\u2019Dea E, Hoffmann A. The regulatory logic of the NF-kappaB signaling system. Cold Spring Harb Perspect Biol. 2010;2:a000216.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/ni.2446","volume":"13","author":"VF-S Shih","year":"2012","unstructured":"Shih VF-S, Davis-Turak J, Macal M, et al. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-\u03baB pathways. Nat Immunol. 2012;13:1162\u201370.","journal-title":"Nat Immunol"},{"key":"14_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113940","volume":"43","author":"SMT Rahman","year":"2024","unstructured":"Rahman SMT, Singh A, Lowe S, et al. Co-imaging of RelA and c-Rel reveals features of NF-\u03baB signaling for ligand discrimination. Cell Rep. 2024;43:113940.","journal-title":"Cell Rep"},{"key":"14_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10761","volume":"7","author":"J Xu","year":"2016","unstructured":"Xu J, Zhou L, Ji L, et al. The REG\u03b3-proteasome forms a regulatory circuit with I\u03baB\u025b and NF\u03baB in experimental colitis. Nat Commun. 2016;7:10761.","journal-title":"Nat Commun"},{"key":"14_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309686121","volume":"121","author":"H Vaidehi Narayanan","year":"2024","unstructured":"Vaidehi Narayanan H, Xiang MY, Chen Y, et al. Direct observation correlates NF\u03baB c-Rel in B cells with activating and terminating their proliferative program. Proc Natl Acad Sci U S A. 2024;121:e2309686121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8068","volume":"6","author":"R Tsui","year":"2015","unstructured":"Tsui R, Kearns JD, Lynch C, et al. I\u03baB\u03b2 enhances the generation of the low-affinity NF\u03baB\/RelA homodimer. Nat Commun. 2015;6:7068.","journal-title":"Nat Commun"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/nature09283","volume":"466","author":"P Rao","year":"2010","unstructured":"Rao P, Hayden MS, Long M, et al. IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature. 2010;466:1115\u20139.","journal-title":"Nature"},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"27657","DOI":"10.1074\/jbc.M103426200","volume":"276","author":"S Yamazaki","year":"2001","unstructured":"Yamazaki S, Muta T, Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J Biol Chem. 2001;276:27657\u201362.","journal-title":"J Biol Chem"},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1101\/gad.351630.124","volume":"38","author":"AE Daly","year":"2024","unstructured":"Daly AE, Yeh G, Soltero S, Smale ST. Selective regulation of a defined subset of inflammatory and immunoregulatory genes by an NF-\u03baB p50-I\u03baB\u03b6 pathway. Genes Dev. 2024;38:536\u201353.","journal-title":"Genes Dev"},{"key":"14_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1101\/gad.351892.124","volume":"38","author":"N Zhu","year":"2024","unstructured":"Zhu N, Rogers WE, Heidary DK, Huxford T. Structural and biochemical analyses of the nuclear I\u03baB\u03b6 protein in complex with the NF-\u03baB p50 homodimer. Genes Dev. 2024;38:528\u201335.","journal-title":"Genes Dev"},{"key":"14_CR60","doi-asserted-by":"publisher","first-page":"49995","DOI":"10.1074\/jbc.M404246200","volume":"279","author":"J Wessells","year":"2004","unstructured":"Wessells J, Baer M, Young HA, et al. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem. 2004;279:49995\u201350003.","journal-title":"J Biol Chem"},{"key":"14_CR61","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nri2655","volume":"9","author":"M Pasparakis","year":"2009","unstructured":"Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9:778\u201388.","journal-title":"Nat Rev Immunol"},{"key":"14_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","volume":"118","author":"FR Greten","year":"2004","unstructured":"Greten FR, Eckmann L, Greten TF, et al. IKkbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285\u201396.","journal-title":"Cell"},{"key":"14_CR63","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000141","volume":"1","author":"M Karin","year":"2009","unstructured":"Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009;1:a000141.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1646","volume":"16","author":"BN Rodriguez","year":"2024","unstructured":"Rodriguez BN, Huang H, Chia JJ, Hoffmann A. The noncanonical NF\u03baB pathway: regulatory mechanisms in health and disease. WIREs Mech Dis. 2024;16:e1646.","journal-title":"WIREs Mech Dis"},{"key":"14_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","volume":"23","author":"TH Watts","year":"2005","unstructured":"Watts TH. TNF\/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005;23:23\u201368.","journal-title":"Annu Rev Immunol"},{"key":"14_CR66","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1172\/JCI44943","volume":"121","author":"SE Murray","year":"2011","unstructured":"Murray SE, Polesso F, Rowe AM, et al. NF-\u03baB\u2013inducing kinase plays an essential T cell\u2013intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. J Clin Invest. 2011;121:4775\u201386.","journal-title":"J Clin Invest"},{"key":"14_CR67","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"S-C Sun","year":"2017","unstructured":"Sun S-C. The non-canonical NF-\u03bab pathway in immunity and inflammation. Nat Rev Immunol. 2017;17:545\u201358.","journal-title":"Nat Rev Immunol"},{"key":"14_CR68","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1038\/s44318-024-00182-6","volume":"43","author":"A Deka","year":"2024","unstructured":"Deka A, Kumar N, Basu S, et al. Non-canonical NF-\u03baB signaling limits the tolerogenic \u03b2-catenin-Raldh2 axis in gut dendritic cells to exacerbate intestinal pathologies. EMBO J. 2024;43:3895\u2013915.","journal-title":"EMBO J"},{"key":"14_CR69","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.bbrc.2007.06.017","volume":"359","author":"B Lamothe","year":"2007","unstructured":"Lamothe B, Webster WK, Gopinathan A, et al. Traf6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem Biophys Res Commun. 2007;359:1044\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR70","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2009.04.033","volume":"34","author":"OV Savinova","year":"2009","unstructured":"Savinova OV, Hoffmann A, Ghosh G. The Nfkb1 and Nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes. Mol Cell. 2009;34:591\u2013602.","journal-title":"Mol Cell"},{"key":"14_CR71","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05648","volume":"4","author":"B Banoth","year":"2015","unstructured":"Banoth B, Chatterjee B, Vijayaragavan B, et al. Stimulus-selective crosstalk via the NF-\u03bab signaling system reinforces innate immune response to alleviate gut infection. Elife. 2015;4:e05648.","journal-title":"Elife"},{"key":"14_CR72","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/ni.1676","volume":"9","author":"BJ Zarnegar","year":"2008","unstructured":"Zarnegar BJ, Wang Y, Mahoney DJ, et al. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol. 2008;9:1371\u20138.","journal-title":"Nat Immunol"},{"key":"14_CR73","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1073\/pnas.032665099","volume":"99","author":"H Dadgostar","year":"2002","unstructured":"Dadgostar H, Zarnegar B, Hoffmann A, et al. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc Natl Acad Sci U S A. 2002;99:1497\u2013502.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, et al. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev. 2009;229:152\u201372.","journal-title":"Immunol Rev"},{"key":"14_CR75","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.celrep.2014.11.024","volume":"9","author":"JV Almaden","year":"2014","unstructured":"Almaden JV, Tsui R, Liu YC, et al. A pathway switch directs BAFF signaling to distinct NF\u03baB transcription factors in maturing and proliferating B cells. Cell Rep. 2014;9:2098\u2013111.","journal-title":"Cell Rep"},{"key":"14_CR76","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S1097-2765(03)00227-2","volume":"11","author":"S Saccani","year":"2003","unstructured":"Saccani S, Pantano S, Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell. 2003;11:1563\u201374.","journal-title":"Mol Cell"},{"key":"14_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00767-9","volume":"11","author":"HI Navarro","year":"2025","unstructured":"Navarro HI, Daly AE, Rodriguez B, et al. NF-\u03baB relB suppresses the inflammatory gene expression programs of dendritic cells by competing with relA for binding to target gene promoters. Cell Discov. 2025;11:13.","journal-title":"Cell Discov"},{"key":"14_CR78","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1073\/pnas.0707959105","volume":"105","author":"B Zarnegar","year":"2008","unstructured":"Zarnegar B, Yamazaki S, He JQ, Cheng G. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci U S A. 2008;105:3503\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR79","doi-asserted-by":"publisher","first-page":"ra41","DOI":"10.1126\/scisignal.2000778","volume":"3","author":"B Razani","year":"2010","unstructured":"Razani B, Zarnegar B, Ytterberg AJ, et al. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation. Sci Signal. 2010;3:ra41.","journal-title":"Sci. Signal."},{"key":"14_CR80","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/ni.1678","volume":"9","author":"S Vallabhapurapu","year":"2008","unstructured":"Vallabhapurapu S, Matsuzawa A, Zhang W, et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol. 2008;9:1364\u201370.","journal-title":"Nat Immunol"},{"key":"14_CR81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","volume":"21","author":"S-C Sun","year":"2011","unstructured":"Sun S-C. Non-canonical NF-\u03baB signaling pathway. Cell Res. 2011;21:71\u201385.","journal-title":"Cell Res"},{"key":"14_CR82","doi-asserted-by":"publisher","first-page":"12324","DOI":"10.1074\/jbc.M707898200","volume":"283","author":"AJ Fusco","year":"2008","unstructured":"Fusco AJ, Savinova OV, Talwar R, et al. Stabilization of RelB requires multidomain interactions with p100\/p52. J Biol Chem. 2008;283:12324\u201332.","journal-title":"J Biol Chem"},{"key":"14_CR83","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1093\/emboj\/20.23.6805","volume":"20","author":"G Xiao","year":"2001","unstructured":"Xiao G. Retroviral oncoprotein Tax induces processing of NF-kappaB2\/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 2001;20:6805\u201315.","journal-title":"EMBO J"},{"key":"14_CR84","first-page":"1495","volume":"293","author":"U Senftleben","year":"2001","unstructured":"Senftleben U, Cao Y, Xiao G,\u00a0et al. Activation by IKKalpha of a second, evolutionary conserved. NF-kappa B signaling pathway Science. 2001;293:1495\u20139.","journal-title":"NF-kappa B signaling pathway Science"},{"key":"14_CR85","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1084\/jem.20061166","volume":"203","author":"JQ He","year":"2006","unstructured":"He JQ, Zarnegar B, Oganesyan G, et al. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency. J Exp Med. 2006;203:2413\u20138.","journal-title":"J Exp Med"},{"key":"14_CR86","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","volume":"12","author":"CM Annunziata","year":"2007","unstructured":"Annunziata CM, Davis RE, Demchenko Y, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12:115\u201330.","journal-title":"Cancer Cell"},{"key":"14_CR87","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490:116\u201320.","journal-title":"Nature"},{"key":"14_CR88","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/icb.2011.111","volume":"90","author":"FB Vincent","year":"2012","unstructured":"Vincent FB, Morand EF, Mackay F. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus. Immunol Cell Biol. 2012;90:293\u2013303.","journal-title":"Immunol Cell Biol"},{"key":"14_CR89","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cytogfr.2008.04.005","volume":"19","author":"S Basak","year":"2008","unstructured":"Basak S, Hoffmann A. Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev. 2008;19:187\u201397.","journal-title":"Cytokine Growth Factor Rev"},{"key":"14_CR90","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","volume":"21","author":"F Mackay","year":"2003","unstructured":"Mackay F, Schneider P, Rennert P, Browning J. BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003;21:231\u201364.","journal-title":"Annu Rev Immunol"},{"key":"14_CR91","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1073\/pnas.1816000116","volume":"116","author":"S Mitchell","year":"2019","unstructured":"Mitchell S, Hoffmann A. Substrate complex competition is a regulatory motif that allows NF\u03baB RelA to license but not amplify NF\u03baB RelB. Proc Natl Acad Sci U S A. 2019;116:10592\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0280-5","volume":"8","author":"KAP de Oliveira","year":"2016","unstructured":"de Oliveira KAP, Kaergel E, Heinig M, et al. A roadmap of constitutive NF-\u03bab activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses. Genome Med. 2016;8:28.","journal-title":"Genome Med"},{"key":"14_CR93","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.molcel.2014.01.026","volume":"53","author":"REC Lee","year":"2014","unstructured":"Lee REC, Walker SR, Savery K, et al. Fold change of nuclear NF-\u03baB determines TNF-induced transcription in single cells. Mol Cell. 2014;53:867\u201379.","journal-title":"Mol Cell"},{"key":"14_CR94","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430:694\u20139.","journal-title":"Nature"},{"key":"14_CR95","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/ng.202","volume":"40","author":"SL Musone","year":"2008","unstructured":"Musone SL, Taylor KE, Lu TT, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40:1062\u20134.","journal-title":"Nat Genet"},{"key":"14_CR96","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036418","volume":"12","author":"A Martens","year":"2020","unstructured":"Martens A, van Loo G. A20 at the crossroads of cell death, inflammation, and autoimmunity. Cold Spring Harb Perspect Biol. 2020;12:a036418.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14_CR97","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","volume":"26","author":"MS Hayden","year":"2012","unstructured":"Hayden MS, Ghosh S. NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012;26:203\u201334.","journal-title":"Genes Dev"},{"key":"14_CR98","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-065X.2011.01091.x","volume":"246","author":"ST Smale","year":"2012","unstructured":"Smale ST. Dimer-specific regulatory mechanisms within the NF-\u03baB family of transcription factors. Immunol Rev. 2012;246:193\u2013204.","journal-title":"Immunol Rev"},{"key":"14_CR99","first-page":"1","volume":"349","author":"T Huxford","year":"2011","unstructured":"Huxford T, Hoffmann A, Ghosh G. Understanding the logic of I\u03baB:NF-\u03baB regulation in structural terms. Curr Top Microbiol Immunol. 2011;349:1\u201324.","journal-title":"Curr Top Microbiol Immunol"},{"key":"14_CR100","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1093\/emboj\/cdg534","volume":"22","author":"A Hoffmann","year":"2003","unstructured":"Hoffmann A, Leung TH, Baltimore D. Genetic analysis of NF-kappaB\/Rel transcription factors defines functional specificities. EMBO J. 2003;22:5530\u20139.","journal-title":"EMBO J"},{"key":"14_CR101","doi-asserted-by":"publisher","first-page":"12705","DOI":"10.1073\/pnas.230436397","volume":"97","author":"S Sanjabi","year":"2000","unstructured":"Sanjabi S, Hoffmann A, Liou HC, et al. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc Natl Acad Sci U S A. 2000;97:12705\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR102","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.celrep.2012.08.042","volume":"2","author":"VY-F Wang","year":"2012","unstructured":"Wang VY-F, Huang W, Asagiri M, et al. The transcriptional specificity of NF-\u03baB dimers is coded within the \u03baB DNA response elements. Cell Rep. 2012;2:824\u201339.","journal-title":"Cell Rep"},{"key":"14_CR103","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-065X.2012.01103.x","volume":"246","author":"G Natoli","year":"2012","unstructured":"Natoli G. NF-\u03baB and chromatin: ten years on the path from basic mechanisms to candidate drugs. Immunol Rev. 2012;246:183\u201392.","journal-title":"Immunol Rev"},{"key":"14_CR104","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1038\/sj.onc.1209937","volume":"25","author":"ND Perkins","year":"2006","unstructured":"Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene. 2006;25:6717\u201330.","journal-title":"Oncogene"},{"key":"14_CR105","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1126\/science.abc0269","volume":"372","author":"QJ Cheng","year":"2021","unstructured":"Cheng QJ, Ohta S, Sheu KM, et al. NF-\u03baB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages. Science. 2021;372:1349\u201353.","journal-title":"Science"},{"key":"14_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111076","volume":"40","author":"J Kim","year":"2022","unstructured":"Kim J, Sheu KM, Cheng QJ, et al. Stochastic models of nucleosome dynamics reveal regulatory rules of stimulus-induced epigenome remodeling. Cell Rep. 2022;40:11076.","journal-title":"Cell Rep"},{"key":"14_CR107","doi-asserted-by":"publisher","DOI":"10.1126\/stke.11pe1","volume":"1","author":"G Natoli","year":"2008","unstructured":"Natoli G, Chiocca S. Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci Signal. 2008;1:pe1.","journal-title":"Sci Signal"},{"key":"14_CR108","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-\u03baB signaling pathways. Nat Immunol. 2011;12:695\u2013708.","journal-title":"Nat Immunol"},{"key":"14_CR109","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1385\/CT:6:2:111","volume":"6","author":"AR Brasier","year":"2006","unstructured":"Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol. 2006;6:111\u201330.","journal-title":"Cardiovasc Toxicol"},{"key":"14_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40503-y","volume":"9","author":"Q Cheng","year":"2019","unstructured":"Cheng Q, Behzadi F, Sen S, et al. Sequential conditioning-stimulation reveals distinct gene- and stimulus-specific effects of type I and II IFN on human macrophage functions. Sci Rep. 2019;9:5288.","journal-title":"Sci Rep"},{"key":"14_CR111","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cels.2017.01.012","volume":"4","author":"CS Cheng","year":"2017","unstructured":"Cheng CS, Behar MS, Suryawanshi GW, et al. Iterative Modeling Reveals Evidence of Sequential Transcriptional Control Mechanisms. Cell Syst. 2017;4:330-343.e5.","journal-title":"Cell Syst"},{"key":"14_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002401","volume":"7","author":"L Escoubet-Lozach","year":"2011","unstructured":"Escoubet-Lozach L, Benner C, Kaikkonen MU, et al. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 2011;7:e1002401.","journal-title":"PLoS Genet"},{"key":"14_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009095","volume":"17","author":"N Wang","year":"2021","unstructured":"Wang N, Lefaudeux D, Mazumder A, et al. Identifying the combinatorial control of signal-dependent transcription factors. PLoS Comput Biol. 2021;17:e1009095.","journal-title":"PLoS Comput Biol"},{"key":"14_CR114","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1101\/gad.244749.114","volume":"28","author":"AB Caldwell","year":"2014","unstructured":"Caldwell AB, Cheng Z, Vargas JD, et al. Network dynamics determine the autocrine and paracrine signaling functions of TNF. Genes Dev. 2014;28:2120\u201333.","journal-title":"Genes Dev"},{"key":"14_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34635-5","volume":"13","author":"D Lefaudeux","year":"2022","unstructured":"Lefaudeux D, Sen S, Jiang K, et al. Kinetics of mRNA nuclear export regulate innate immune response gene expression. Nat Commun. 2022;13:7197.","journal-title":"Nat Commun"},{"key":"14_CR116","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001501","volume":"4","author":"CS Cheng","year":"2011","unstructured":"Cheng CS, Feldman KE, Lee J, et al. The specificity of innate immune responses is enforced by repression of interferon response elements by NF-\u03baB p50. Sci Signal. 2011;4:ra11.","journal-title":"Sci Signal"},{"key":"14_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/cells5020022","volume":"5","author":"V Baud","year":"2016","unstructured":"Baud V, Collares D. Post-translational modifications of RelB NF-\u03baB subunit and associated functions. Cells. 2016;5:22.","journal-title":"Cells"},{"key":"14_CR118","doi-asserted-by":"publisher","first-page":"19090","DOI":"10.1073\/pnas.1901056116","volume":"116","author":"H Shen","year":"2019","unstructured":"Shen H, Ji Y, Xiong Y, et al. Medullary thymic epithelial NF-kB-inducing kinase (NIK)\/IKK\u03b1 pathway shapes autoimmunity and liver and lung homeostasis in mice. Proc Natl Acad Sci U S A. 2019;116:19090\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/imr.12033","volume":"252","author":"H Oh","year":"2013","unstructured":"Oh H, Ghosh S. NF-\u03baB: roles and regulation in different CD4(+) T-cell subsets. Immunol Rev. 2013;252:41\u201351.","journal-title":"Immunol Rev"},{"issue":"165","key":"14_CR120","first-page":"5004","volume":"1950","author":"T Hettmann","year":"2000","unstructured":"Hettmann T, Leiden JM. NF-kappa B is required for the positive selection of CD8+ thymocytes. J Immunol Baltim Md. 2000;1950(165):5004\u201310.","journal-title":"J Immunol Baltim Md"},{"key":"14_CR121","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ni.2038","volume":"12","author":"M Pepper","year":"2011","unstructured":"Pepper M, Jenkins MK. Origins of CD4(+) effector and central memory T cells. Nat Immunol. 2011;12:467\u201371.","journal-title":"Nat Immunol"},{"key":"14_CR122","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/1947601911421925","volume":"2","author":"TD Gilmore","year":"2011","unstructured":"Gilmore TD, Gerondakis S. The c-Rel transcription factor in development and disease. Genes Cancer. 2011;2:695\u2013711.","journal-title":"Genes Cancer"},{"key":"14_CR123","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20145554","volume":"11","author":"MN Shokhirev","year":"2015","unstructured":"Shokhirev MN, Almaden J, Davis-Turak J, et al. A multi-scale approach reveals that NF-\u03baB c-Rel enforces a B-cell decision to divide. Mol Syst Biol. 2015;11:783.","journal-title":"Mol Syst Biol"},{"key":"14_CR124","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2014-10-606988","volume":"127","author":"JV Almaden","year":"2016","unstructured":"Almaden JV, Liu YC, Yang E, et al. B-cell survival and development controlled by the coordination of NF-\u03baB family members RelB and c-Rel. Blood. 2016;127:1276\u201386.","journal-title":"Blood"},{"key":"14_CR125","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0076-6879(08)01610-8","volume":"446","author":"IL Ch\u2019en","year":"2008","unstructured":"Ch\u2019en IL, Hedrick SM, Hoffmann A. NF-kappaB as a determinant of distinct cell death pathways. Methods Enzymol. 2008;446:175\u201387.","journal-title":"Methods Enzymol"},{"key":"14_CR126","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1126\/science.274.5288.782","volume":"274","author":"AA Beg","year":"1996","unstructured":"Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 1996;274:782\u20134.","journal-title":"Science"},{"key":"14_CR127","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209677","volume":"16","author":"M Oliver Metzig","year":"2020","unstructured":"Oliver Metzig M, Tang Y, Mitchell S, et al. An incoherent feedforward loop interprets NF\u03baB\/RelA dynamics to determine TNF-induced necroptosis decisions. Mol Syst Biol. 2020;16:e9677.","journal-title":"Mol Syst Biol"},{"key":"14_CR128","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.bpj.2023.01.035","volume":"122","author":"GV Ildefonso","year":"2023","unstructured":"Ildefonso GV, Oliver Metzig M, Hoffmann A, et al. A biochemical necroptosis model explains cell-type-specific responses to cell death cues. Biophys J. 2023;122:817\u201334.","journal-title":"Biophys J"},{"key":"14_CR129","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/biomedicines10050974","volume":"10","author":"M Oliver Metzig","year":"2022","unstructured":"Oliver Metzig M, Hoffmann A. Controlling cancer cell death types to optimize anti-tumor immunity. Biomedicines. 2022;10:974.","journal-title":"Biomedicines"},{"key":"14_CR130","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-065X.2012.01101.x","volume":"246","author":"KW McCool","year":"2012","unstructured":"McCool KW, Miyamoto S. DNA damage-dependent NF-\u03bab activation: NEMO turns nuclear signaling inside out. Immunol Rev. 2012;246:311\u201326.","journal-title":"Immunol Rev"},{"key":"14_CR131","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1084\/jem.20160204","volume":"213","author":"W-H Liu","year":"2016","unstructured":"Liu W-H, Kang SG, Huang Z, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901\u201319.","journal-title":"J Exp Med"},{"key":"14_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S. NF-\u03baB, inflammation, and metabolic disease. Cell Metab. 2011;13:11\u201322.","journal-title":"Cell Metab"},{"key":"14_CR133","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011;21:159\u201368.","journal-title":"Cell Res"},{"key":"14_CR134","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","volume":"213","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213:15\u201323.","journal-title":"J Exp Med"},{"key":"14_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02403-1","volume":"11","author":"Y Shi","year":"2025","unstructured":"Shi Y, Zhang H, Miao C. Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives. Cell Death Discov. 2025;11:123.","journal-title":"Cell Death Discov"},{"key":"14_CR136","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2008.10.052","volume":"136","author":"TLA Kawahara","year":"2009","unstructured":"Kawahara TLA, Michishita E, Adler AS, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell. 2009;136:62\u201374.","journal-title":"Cell"},{"key":"14_CR137","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117:244\u201379.","journal-title":"Pharmacol Ther"},{"issue":"173","key":"14_CR138","first-page":"7003","volume":"1950","author":"ME Poynter","year":"2004","unstructured":"Poynter ME, Cloots R, van Woerkom T, et al. NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol Baltim Md. 2004;1950(173):7003\u20139.","journal-title":"J Immunol Baltim Md"},{"key":"14_CR139","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/labinvest.3700456","volume":"86","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ. Transcription factors in airway diseases. Lab Invest. 2006;86:867\u201372.","journal-title":"Lab Invest"},{"key":"14_CR140","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood.2024025598","volume":"145","author":"A Singh","year":"2025","unstructured":"Singh A, Chia JJ, Rao DS, Hoffmann A. Population dynamics modeling reveals that myeloid bias involves both HSC differentiation and progenitor proliferation biases. Blood. 2025;145:1293\u2013308.","journal-title":"Blood"},{"key":"14_CR141","doi-asserted-by":"crossref","unstructured":"Chia JJ, Singh A, Lin YS, et al. Distinct roles for NF-\u03baB in hematopoietic stem cells and the bone marrow milieu in promoting hematopoietic aging. Cell Rep. 2025;44:116193.","DOI":"10.1016\/j.celrep.2025.116193"},{"key":"14_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1476030","volume":"15","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yi Y, Han C, Shi B. NF-\u03baB signaling pathway in tumor microenvironment. Front Immunol. 2024;15:1476030.","journal-title":"Front Immunol"},{"key":"14_CR143","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001;293:1673\u20137.","journal-title":"Science"},{"key":"14_CR144","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/art.30613","volume":"63","author":"R Furie","year":"2011","unstructured":"Furie R, Petri M, Zamani O, et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011;63:3918\u201330.","journal-title":"Arthritis Rheum"},{"key":"14_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102946","volume":"137","author":"N Sharfe","year":"2023","unstructured":"Sharfe N, Dalal I, Naghdi Z, et al. NF\u03bab pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity. J Autoimmun. 2023;137:102946.","journal-title":"J Autoimmun"},{"key":"14_CR146","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.jaci.2023.06.024","volume":"152","author":"HI Navarro","year":"2023","unstructured":"Navarro HI, Liu Y, Fraser A, et al. Relb-deficient autoinflammatory pathology presents as interferonopathy, but in mice is interferon-independent. J Allergy Clin Immunol. 2023;152:1261\u201372.","journal-title":"J Allergy Clin Immunol"},{"key":"14_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00767-9","volume":"11","author":"HI Navarro","year":"2025","unstructured":"Navarro HI, Daly AE, Rodriguez B, et al. NF-\u03baB relB suppresses the inflammatory gene expression programs of dendritic cells by competing with relA for binding to target gene promoters. Cell Discov. 2025;11:13.","journal-title":"Cell Discov"},{"key":"14_CR148","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMoa030288","volume":"348","author":"PG Richardson","year":"2003","unstructured":"Richardson PG, Barlogie B, Berenson J, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003;348:2609\u201317.","journal-title":"N Engl J Med"},{"key":"14_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/cells7090115","volume":"7","author":"JA Prescott","year":"2018","unstructured":"Prescott JA, Cook SJ. Targeting IKK\u03b2 in cancer: challenges and opportunities for the therapeutic utilisation of IKK\u03b2 inhibitors. Cells. 2018;7:115.","journal-title":"Cells"},{"key":"14_CR150","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1476-5381.2010.00839.x","volume":"160","author":"D De Silva","year":"2010","unstructured":"De Silva D, Mitchell MD, Keelan JA. Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-kappaB kinase (IKK) inhibitors. Br J Pharmacol. 2010;160:1808\u201322.","journal-title":"Br J Pharmacol"},{"key":"14_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930986","volume":"13","author":"MV Haselager","year":"2022","unstructured":"Haselager MV, Eldering E. The therapeutic potential of targeting NIK in B cell malignancies. Front Immunol. 2022;13:930986.","journal-title":"Front Immunol"},{"key":"14_CR152","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jgm.1546","volume":"13","author":"D De Stefano","year":"2011","unstructured":"De Stefano D, Ungaro F, Giovino C, et al. Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-\u03baB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells. J Gene Med. 2011;13:200\u20138.","journal-title":"J Gene Med"},{"key":"14_CR153","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","volume":"18","author":"M Schapira","year":"2019","unstructured":"Schapira M, Calabrese MF, Bullock AN, Crews CM. Targeted protein degradation: expanding the toolbox. Nat Rev Drug Discov. 2019;18:949\u201363.","journal-title":"Nat Rev Drug Discov"},{"key":"14_CR154","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1:a000034.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14_CR155","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJM199707173370301","volume":"337","author":"LW Moreland","year":"1997","unstructured":"Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 1997;337:141\u20137.","journal-title":"N Engl J Med"},{"key":"14_CR156","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023\u201338.","journal-title":"Lancet"},{"key":"14_CR157","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098\u2013104.","journal-title":"N Engl J Med"},{"key":"14_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00152","volume":"6","author":"K Bendtzen","year":"2015","unstructured":"Bendtzen K. Immunogenicity of anti-TNF-\u03b1 biotherapies: i. Individualized medicine based on immunopharmacological evidence. Front Immunol. 2015;6:152.","journal-title":"Front Immunol"},{"key":"14_CR159","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756\u201365.","journal-title":"N Engl J Med"},{"key":"14_CR160","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115\u20137.","journal-title":"J Oral Maxillofac Surg"},{"key":"14_CR161","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","volume":"41","author":"B Bresnihan","year":"1998","unstructured":"Bresnihan B, Alvaro-Gracia JM, Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998;41:2196\u2013204.","journal-title":"Arthritis Rheum"},{"key":"14_CR162","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360:2416\u201325.","journal-title":"N Engl J Med"},{"key":"14_CR163","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720\u201332.","journal-title":"Blood"},{"key":"14_CR164","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1124\/jpet.105.097584","volume":"317","author":"D Wen","year":"2006","unstructured":"Wen D,\u00a0Nong Y, Morgan JG, et al. A selective small molecule IkappaB kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells. J Pharmacol Exp Ther. 2006;317:989\u20131001.","journal-title":"J Pharmacol Exp Ther"},{"key":"14_CR165","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.joca.2016.08.010","volume":"25","author":"K Grothe","year":"2017","unstructured":"Grothe K, Flechsenhar K, Paehler T, et al. I\u03bab kinase inhibition as a potential treatment of osteoarthritis - results of a clinical proof-of-concept study. Osteoarthritis Cartilage. 2017;25:46\u201352.","journal-title":"Osteoarthritis Cartilage"},{"key":"14_CR166","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.18632\/oncotarget.2128","volume":"5","author":"YN Demchenko","year":"2014","unstructured":"Demchenko YN, Brents LA, Li Z, et al. Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB. Oncotarget. 2014;5:4554\u201366.","journal-title":"Oncotarget"},{"key":"14_CR167","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369:32\u201342.","journal-title":"N Engl J Med"},{"key":"14_CR168","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1182\/blood.2021014162","volume":"139","author":"Y Song","year":"2022","unstructured":"Song Y, Zhou K, Zou D, et al. Zanubrutinib in relapsed\/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study. Blood. 2022;139:3148\u201358.","journal-title":"Blood"},{"key":"14_CR169","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.med.57.042905.122625","volume":"57","author":"PG Richardson","year":"2006","unstructured":"Richardson PG, Mitsiades C, Hideshima T, Anderson KC. Bortezomib: proteasome inhibition as an effective anticancer therapy. Annu Rev Med. 2006;57:33\u201347.","journal-title":"Annu Rev Med"},{"key":"14_CR170","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","volume":"112","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood. 2008;112:1593\u20139.","journal-title":"Blood"},{"key":"14_CR171","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1182\/blood-2012-05-425934","volume":"120","author":"DS Siegel","year":"2012","unstructured":"Siegel DS, Martin T, Wang M, et al. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. Blood. 2012;120:2817\u201325.","journal-title":"Blood"},{"key":"14_CR172","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1516282","volume":"374","author":"P Moreau","year":"2016","unstructured":"Moreau P, Masszi T, Grzasko N, et al. Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma. N Engl J Med. 2016;374:1621\u201334.","journal-title":"N Engl J Med"},{"key":"14_CR173","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","volume":"148","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ. How corticosteroids control inflammation: Quintiles prize lecture 2005. Br J Pharmacol. 2006;148:245\u201354.","journal-title":"Br J Pharmacol"},{"key":"14_CR174","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","volume":"96","author":"H Sch\u00e4cke","year":"2002","unstructured":"Sch\u00e4cke H, D\u00f6cke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96:23\u201343.","journal-title":"Pharmacol Ther"},{"key":"14_CR175","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol. 2014;192:5459\u201368.","journal-title":"J Immunol"},{"key":"14_CR176","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","volume":"118","author":"MF Marmor","year":"2011","unstructured":"Marmor MF, Kellner U, Lai TYY, et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118:415\u201322.","journal-title":"Ophthalmology"},{"key":"14_CR177","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998;396:77\u201380.","journal-title":"Nature"},{"key":"14_CR178","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(16)32404-7","volume":"390","author":"A Lanas","year":"2017","unstructured":"Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390:613\u201324.","journal-title":"Lancet"},{"key":"14_CR179","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010;327:1345\u201350.","journal-title":"Science"},{"issue":"24","key":"14_CR180","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Sonneveld P, Schuster MW, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med. 2005;352(24):2487\u201398.","journal-title":"N Engl J Med"},{"key":"14_CR181","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1182\/blood.V98.3.762","volume":"98","author":"D Kube","year":"2001","unstructured":"Kube D, Holtick U, Vockerodt M, et al. STAT3 is constitutively activated in Hodgkin cell lines. Blood. 2001;98:762\u201370.","journal-title":"Blood"},{"key":"14_CR182","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan HC, Cooper MJ, Cogswell PC, et al. Akt-dependent regulation of NF-kappaB is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008;22:1490\u2013500.","journal-title":"Genes Dev"},{"key":"14_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184510","volume":"13","author":"J Silke","year":"2021","unstructured":"Silke J, O\u2019Reilly LA. NF-\u03baB and pancreatic cancer; chapter and verse. Cancers (Basel). 2021;13:4510.","journal-title":"Cancers (Basel)"},{"key":"14_CR184","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S1470-2045(14)71125-8","volume":"15","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Berdeja JG, Niesvizky R, et al. Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1\/2 study. Lancet Oncol. 2014;15:1503\u201312.","journal-title":"Lancet Oncol"},{"key":"14_CR185","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1074\/jbc.M209677200","volume":"278","author":"JR Burke","year":"2003","unstructured":"Burke JR, Pattoli MA, Gregor KR, et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2003;278:1450\u20136.","journal-title":"J Biol Chem"},{"key":"14_CR186","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.gde.2010.09.007","volume":"20","author":"M Behar","year":"2010","unstructured":"Behar M, Hoffmann A. Understanding the temporal codes of intra-cellular signals. Curr Opin Genet Dev. 2010;20:684\u201393.","journal-title":"Curr Opin Genet Dev"},{"key":"14_CR187","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cell.2013.09.018","volume":"155","author":"M Behar","year":"2013","unstructured":"Behar M, Barken D, Werner SL, Hoffmann A. The dynamics of signaling as a pharmacological target. Cell. 2013;155:448\u201361.","journal-title":"Cell"},{"key":"14_CR188","doi-asserted-by":"crossref","unstructured":"Bozich ER, Guo X, Wilson JL, Hoffmann A. A computational workflow for assessing drug effects on temporal signaling dynamics reveals robustness in stimulus-specific NF\u03bab signaling. PLoS Comput Biol. 2025;21:e1013344.","DOI":"10.1371\/journal.pcbi.1013344"},{"key":"14_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201902232","volume":"15","author":"B Saleh","year":"2019","unstructured":"Saleh B, Dhaliwal HK, Portillo-Lara R, et al. Local immunomodulation using an adhesive hydrogel loaded with miRNA-laden nanoparticles promotes wound healing. Small Weinh Bergstr Ger. 2019;15:e1902232.","journal-title":"Small Weinh Bergstr Ger"},{"key":"14_CR190","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson DP, Mares A, Smith IED, et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat Chem Biol. 2015;11:611\u20137.","journal-title":"Nat Chem Biol"},{"key":"14_CR191","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067\u201373.","journal-title":"Nature"},{"key":"14_CR192","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba7365","volume":"367","author":"EA Stadtmauer","year":"2020","unstructured":"Stadtmauer EA, Fraietta JA, Davis MM, et al. CRISPR-engineered T cells in patients with refractory cancer. Science. 2020;367:eaba7365.","journal-title":"Science"},{"key":"14_CR193","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533:420\u20134.","journal-title":"Nature"},{"key":"14_CR194","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498\u2013503.","journal-title":"Nature"},{"key":"14_CR195","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05098-8","volume":"81","author":"N Ebrahimi","year":"2024","unstructured":"Ebrahimi N, Abdulwahid ARR, Mansouri A,\u00a0et al. Targeting the NF-\u03baB pathway as a potential regulator of immune checkpoints in cancer immunotherapy. Cell Mol Life Sci. 2024;81:106.","journal-title":"Cell Mol Life Sci"},{"key":"14_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10110426","volume":"10","author":"J Struzik","year":"2018","unstructured":"Struzik J, Szulc-D\u0105browska L. NF-\u03baB signaling in targeting tumor cells by oncolytic viruses-therapeutic perspectives. Cancers (Basel). 2018;10:426.","journal-title":"Cancers (Basel)"},{"key":"14_CR197","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ni.2151","volume":"13","author":"T Siggers","year":"2011","unstructured":"Siggers T, Chang AB, Teixeira A, et al. Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-\u03baB family DNA binding. Nat Immunol. 2011;13:95\u2013102.","journal-title":"Nat Immunol"},{"key":"14_CR198","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cell.2004.08.007","volume":"118","author":"TH Leung","year":"2004","unstructured":"Leung TH, Hoffmann A, Baltimore D. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell. 2004;118:453\u201364.","journal-title":"Cell"},{"key":"14_CR199","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.immuni.2021.04.011","volume":"54","author":"A Adelaja","year":"2021","unstructured":"Adelaja A, Taylor B, Sheu KM, et al. Six distinct NF\u03baB signaling codons convey discrete information to distinguish stimuli and enable appropriate macrophage responses. Immunity. 2021;54:916-930.e7.","journal-title":"Immunity"},{"key":"14_CR200","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cels.2019.12.004","volume":"10","author":"S Sen","year":"2020","unstructured":"Sen S, Cheng Z, Sheu KM, et al. Gene regulatory strategies that decode the duration of NF\u03baB dynamics contribute to LPS- versus TNF-specific gene expression. Cell Syst. 2020;10:169\u201382.","journal-title":"Cell Syst"},{"key":"14_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-021-00204-7","volume":"7","author":"M Ando","year":"2021","unstructured":"Ando M, Magi S, Seki M, et al. I\u03baB\u03b1 is required for full transcriptional induction of some NF\u03baB-regulated genes in response to TNF in MCF-7 cells. NPJ Syst Biol Appl. 2021;7:42.","journal-title":"NPJ Syst Biol Appl"},{"key":"14_CR202","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.1250020","volume":"344","author":"H Shinohara","year":"2014","unstructured":"Shinohara H, Behar M, Inoue K, et al. Positive feedback within a kinase signaling complex functions as a switch mechanism for NF-\u03baB activation. Science. 2014;344:760\u20134.","journal-title":"Science"},{"key":"14_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/npjsba.2016.24","volume":"2","author":"K Inoue","year":"2016","unstructured":"Inoue K, Shinohara H, Behar M, et al. Oscillation dynamics underlie functional switching of NF-\u03baB for B-cell activation. NPJ Syst Biol Appl. 2016;2:16024.","journal-title":"NPJ Syst Biol Appl"},{"key":"14_CR204","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature09145","volume":"466","author":"S Tay","year":"2010","unstructured":"Tay S, Hughey JJ, Lee TK, et al. Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature. 2010;466:267\u201371.","journal-title":"Nature"},{"key":"14_CR205","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cels.2022.12.012","volume":"14","author":"KM Sheu","year":"2023","unstructured":"Sheu KM, Guru AA, Hoffmann A. Quantifying stimulus-response specificity to probe the functional state of macrophages. Cell Syst. 2023;14:180-195.e5.","journal-title":"Cell Syst"},{"key":"14_CR206","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255986","volume":"24","author":"S Luecke","year":"2023","unstructured":"Luecke S, Adelaja A, Guo X, et al. Tonic TNF conditioning of macrophages safeguards stimulus-specific inflammatory responses. EMBO Rep. 2023;24:e55986.","journal-title":"EMBO Rep"},{"key":"14_CR207","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-101320-031555","volume":"40","author":"KM Sheu","year":"2022","unstructured":"Sheu KM, Hoffmann A. Functional hallmarks of healthy macrophage responses: their regulatory basis and disease relevance. Annu Rev Immunol. 2022;40:295\u2013321.","journal-title":"Annu Rev Immunol"},{"key":"14_CR208","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1016\/j.molcel.2024.09.023","volume":"84","author":"KM Sheu","year":"2024","unstructured":"Sheu KM, Pimplaskar A, Hoffmann A. Single-cell stimulus-response gene expression trajectories reveal the stimulus specificities of dynamic responses by single macrophages. Mol Cell. 2024;84:4095-4110.e6.","journal-title":"Mol Cell"},{"key":"14_CR209","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cels.2024.05.002","volume":"15","author":"A Singh","year":"2024","unstructured":"Singh A, Sen S, Iter M, et al. Stimulus-response signaling dynamics characterize macrophage polarization states. Cell Syst. 2024;15:563-577.e6.","journal-title":"Cell Syst"},{"key":"14_CR210","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s44320-024-00047-4","volume":"20","author":"S Luecke","year":"2024","unstructured":"Luecke S, Guo X, Sheu KM, et al. Dynamical and combinatorial coding by MAPK p38 and NF\u03baB in the inflammatory response of macrophages. Mol Syst Biol. 2024;20:898\u2013932.","journal-title":"Mol Syst Biol"},{"key":"14_CR211","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63603","volume":"9","author":"M Fomicheva","year":"2020","unstructured":"Fomicheva M, Macara IG. Genome-wide CRISPR screen identifies noncanonical NF-\u03baB signaling as a regulator of densitydependent proliferation. Elife. 2020;9:e63603.","journal-title":"Elife"}],"container-title":["Immunity &amp; Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44466-025-00014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44466-025-00014-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44466-025-00014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:04:46Z","timestamp":1770649486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44466-025-00014-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":211,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s44466-025-00014-0","relation":{},"ISSN":["3059-4774"],"issn-type":[{"value":"3059-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The corresponding author Genhong Cheng is Deputy Editor of the journal Immunity & Inflammation. However, he was not involved in the peer-review or decision-making process for this manuscript. The authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}